With October off to a great start for penny stocks, which small-caps are you watching? The post Top Penny Stocks to Buy This Week? 3 You...
The record rally in Moderna (MRNA) stock has hit a pause as rivals Merck & Company (MRK) and Ridgeback Biotherapeutics came out with an oral antiviral...
Merck & Company (MRK) gained over 8% to close at $81.40 on October 1. Merck is a biopharmaceutical firm whose main product is the PD-L1 inhibitor...
"It Really Is THAT Good" - Wall Street Reacts To Merck's "Big Deal" Drug As we reported earlier this morning, Merck has released what experts say...
Merck said data from the Phase III MOVe-OUT trial showed that 28 of 385 patients (7.3%) who received molnupiravir were either hospitalized or died through Day...
A month after revealing that its monoclonal antibody combination was 77% effective at preventing symptomatic Covid-19 compared to placebo, AstraZeneca says it’s headed to the FDA....
The COVID-19 vaccine market in developed economies is dominated by the likes of Pfizer (PFE) and Moderna (MRNA). These companies have benefitted from an early-mover advantage....
Check out these health care stocks making headlines in the stock market now. The post 4 Top Health Care Stocks To Watch Now Ahead Of Debt...
Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer...
Sen. Johnson: Health Agencies Are "Ignoring Natural Immunity" Authored by Zachary Stieber via The Epoch Times, Top American health officials are ignoring or downplaying so-called natural immunity,...
The post-Covid recovery has been anything but positive for Zoom Video Communications (ZM) stock. In 2020, investors excited about the enterprise communications platform’s unexpected tailwind aggressively...
Initial results from a vaccine trial reported Sept. 20 showed that Pfizer and BioNTech's Covid-19 vaccine might be safe for use in children under 12 years old.
Could these biotech stocks be the booster for your portfolio today? The post Best Biotech Stocks To Buy Now? 4 For Your Watchlist appeared first on...
States See Looming Monoclonal Antibody Crunch As Biden Admin Rations Doses Authored by Zachary Stieber via The Epoch Times, Some states are set to receive fewer...
The U.S. Food and Drug Administration said on Sept. 16 it has revised the FDA's emergency use authorization for Eli Lilly's Covid-19 antibody cocktail to include...
External advisors to the U.S. Food and Drug Administration will meet on Sept. 17 to consider data from Pfizer and BioNTech in support of booster shots....
FDA Says Authorized COVID-19 Vaccines Still Effective, Boosters May Not Be Needed Authored by Jack Phillips via The Epoch Times, The Food and Drug Administration (FDA)...
These dividend stocks are in focus now as investors brace for late September stock market turbulence. The post 3 Dividend Stocks For Your Watchlist Right Now...
There’s no stopping the Moderna (MRNA) juggernaut. Shares are up by 330% year-to-date, with the latest uptick following the company’s annual R&D event. Moderna provided an...
Two weeks ago, Oppenheimer analyst Kevin DeGeeter assured investors that despite there being no specific timeline for Humanigen's (HGEN) lenzilumab hypoxia drug receiving Emergency Use Authorization...
Moderna Inc. is developing a single vaccine that combines a booster dose against Covid-19 with the company's experimental flu shot.
Shares of Humanigen plunged in trading after the company announced the U.S. Food and Drug Administration rejected the company’s Emergency Use Authorization request for lenzilumab, a potential treatment...
Ocugen (OCGN) came into limelight after the company signed a deal to market Bharat Biotech's COVID-19 vaccine (Covaxin) in the United States.
A study published in The Lancet Infectious Diseases found that the Pfizer-BioNTech, Oxford-AstraZeneca or Moderna vaccines resulted in a drop in “long-haul” Covid-19 by 50 percent. According...
Shared in Mesoblast dropped on the last day of August 2021 after the Melbourne-based biotech was told that the company's investigational respiratory treatment for Covid-19 needed to...
A medical student answers questions he gets asked at a COVID-19 vaccine clinic: Efficacy versus real-world effectiveness, immune response and how the mRNA vaccines compare to...
Pfizer Inc. started dosing in a mid-to-late-stage trial of the company's oral antiviral therapy for Covid-19 in non-hospitalized, symptomatic adult patients.
Participants in Novavax Inc.'s late-stage Covid-19 vaccine trial can be considered fully vaccinated two weeks after completing their two-dose vaccine regimen, the U.S. Centers for Disease...
Green Card Applicants Will Soon Need COVID-19 Vaccine To Be Eligible: CDC Authored by Mimi Nguyen Ly via The Epoch Times, Most green card applicants will...
It has been six months since the Johnson & Johnson vaccine received emergency use authorization. What does six months of data show about its efficacy, side...